Thiogenesis Therapeutics, Corp.
TTIPF
$0.585
$0.583436,462.50%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.35M | 2.10M | 2.67M | 3.07M | 3.63M |
| Total Receivables | 35.60K | 39.80K | 61.10K | 54.40K | 34.80K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 35.50K | 42.70K | 33.10K | 24.40K | 34.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 1.42M | 2.18M | 2.77M | 3.15M | 3.70M |
|
|
|||||
| Total Current Assets | 1.42M | 2.18M | 2.77M | 3.15M | 3.70M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 1.42M | 2.18M | 2.77M | 3.15M | 3.70M |
|
|
|||||
| Total Accounts Payable | 1.09M | 679.30K | 387.70K | 78.40K | 225.40K |
| Total Accrued Expenses | -- | 12.00K | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 1.09M | 691.30K | 387.70K | 78.40K | 225.40K |
|
|
|||||
| Total Current Liabilities | 1.09M | 691.30K | 387.70K | 78.40K | 225.40K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.09M | 691.30K | 387.70K | 78.40K | 225.40K |
|
|
|||||
| Common Stock & APIC | 11.89M | 11.28M | 11.22M | 11.60M | 11.44M |
| Retained Earnings | -12.90M | -10.92M | -9.93M | -9.74M | -9.13M |
| Treasury Stock & Other | 1.35M | 1.13M | 1.09M | 1.21M | 1.17M |
| Total Common Equity | 335.00K | 1.49M | 2.38M | 3.07M | 3.47M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 335.00K | 1.49M | 2.38M | 3.07M | 3.47M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 335.00K | 1.49M | 2.38M | 3.07M | 3.47M |
|
|
|||||